Quince Therapeutics, Inc. (QNCX): SCHEDULE 13G/A filed Feb 18, 2025

Form type

SCHEDULE 13G/A

Filing date

Feb 18, 2025

Accession number

0001140361-25-004984

Filer

Quince Therapeutics, Inc. (CIK 1662774)